Fda Launches Real-Time Access Plan For Clinical Trial Data With AstraZeneca And Amgen — The FDA announced a new initiative that would let its reviewers access clinical trial information in real time, aiming to speed and strengthen oversight. AstraZeneca and Amgen are already…
— BizToc (@biztoc.com) 2026-04-28T23:01:03.419Z